vs

Side-by-side financial comparison of Dutch Bros Inc. (BROS) and CLOVER HEALTH INVESTMENTS, CORP. (CLOV). Click either name above to swap in a different company.

CLOVER HEALTH INVESTMENTS, CORP. is the larger business by last-quarter revenue ($487.7M vs $443.6M, roughly 1.1× Dutch Bros Inc.). Dutch Bros Inc. runs the higher net margin — 4.8% vs -10.1%, a 14.9% gap on every dollar of revenue. On growth, CLOVER HEALTH INVESTMENTS, CORP. posted the faster year-over-year revenue change (44.7% vs 29.4%). Dutch Bros Inc. produced more free cash flow last quarter ($8.5M vs $-69.0M). Over the past eight quarters, Dutch Bros Inc.'s revenue compounded faster (27.0% CAGR vs 18.6%).

Dutch Bros Inc., originally written Dutch Bros., is a publicly held drive-through coffee chain in the United States. Founded in 1992 by Dane and Travis Boersma, it is headquartered in Tempe, Arizona, after having been based in Grants Pass, Oregon, for many years prior to 2025. It has company-owned and franchise locations primarily located in the Western United States, although the company has expanded as far east as Orlando, Florida.

Clover Health Investments, Corp. is an American health care company founded in 2014. The company provides Medicare Advantage (MA) insurance plans and operates as a direct contracting entity with the U.S. government. The company manages care for Medicare beneficiaries in 11 states and started trading publicly on January 8, 2021.

BROS vs CLOV — Head-to-Head

Bigger by revenue
CLOV
CLOV
1.1× larger
CLOV
$487.7M
$443.6M
BROS
Growing faster (revenue YoY)
CLOV
CLOV
+15.3% gap
CLOV
44.7%
29.4%
BROS
Higher net margin
BROS
BROS
14.9% more per $
BROS
4.8%
-10.1%
CLOV
More free cash flow
BROS
BROS
$77.4M more FCF
BROS
$8.5M
$-69.0M
CLOV
Faster 2-yr revenue CAGR
BROS
BROS
Annualised
BROS
27.0%
18.6%
CLOV

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
BROS
BROS
CLOV
CLOV
Revenue
$443.6M
$487.7M
Net Profit
$21.4M
$-49.3M
Gross Margin
24.1%
Operating Margin
7.7%
-10.1%
Net Margin
4.8%
-10.1%
Revenue YoY
29.4%
44.7%
Net Profit YoY
491.6%
-123.2%
EPS (diluted)
$0.17

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
BROS
BROS
CLOV
CLOV
Q4 25
$443.6M
$487.7M
Q3 25
$423.6M
$496.6M
Q2 25
$415.8M
$477.6M
Q1 25
$355.2M
$462.3M
Q4 24
$342.8M
$337.0M
Q3 24
$338.2M
$331.0M
Q2 24
$324.9M
$356.3M
Q1 24
$275.1M
$346.9M
Net Profit
BROS
BROS
CLOV
CLOV
Q4 25
$21.4M
$-49.3M
Q3 25
$17.5M
$-24.4M
Q2 25
$25.6M
$-10.6M
Q1 25
$15.4M
$-1.3M
Q4 24
$3.6M
$-22.1M
Q3 24
$12.6M
$-9.2M
Q2 24
$11.9M
$7.4M
Q1 24
$7.1M
$-19.2M
Gross Margin
BROS
BROS
CLOV
CLOV
Q4 25
24.1%
Q3 25
25.2%
Q2 25
28.9%
Q1 25
25.3%
Q4 24
25.7%
Q3 24
26.6%
24.5%
Q2 24
27.8%
30.3%
Q1 24
26.1%
23.6%
Operating Margin
BROS
BROS
CLOV
CLOV
Q4 25
7.7%
-10.1%
Q3 25
9.8%
-4.9%
Q2 25
13.1%
-2.2%
Q1 25
8.7%
-0.3%
Q4 24
4.6%
-6.4%
Q3 24
9.6%
-2.7%
Q2 24
9.9%
2.0%
Q1 24
9.3%
-6.5%
Net Margin
BROS
BROS
CLOV
CLOV
Q4 25
4.8%
-10.1%
Q3 25
4.1%
-4.9%
Q2 25
6.2%
-2.2%
Q1 25
4.3%
-0.3%
Q4 24
1.1%
-6.6%
Q3 24
3.7%
-2.8%
Q2 24
3.7%
2.1%
Q1 24
2.6%
-5.5%
EPS (diluted)
BROS
BROS
CLOV
CLOV
Q4 25
$0.17
Q3 25
$0.14
Q2 25
$0.20
Q1 25
$0.13
Q4 24
$0.03
Q3 24
$0.11
Q2 24
$0.12
Q1 24
$0.08

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
BROS
BROS
CLOV
CLOV
Cash + ST InvestmentsLiquidity on hand
$269.4M
$78.3M
Total DebtLower is stronger
$202.5M
Stockholders' EquityBook value
$680.8M
$308.7M
Total Assets
$3.0B
$541.0M
Debt / EquityLower = less leverage
0.30×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
BROS
BROS
CLOV
CLOV
Q4 25
$269.4M
$78.3M
Q3 25
$267.2M
Q2 25
$254.4M
Q1 25
$316.4M
Q4 24
$293.4M
$194.5M
Q3 24
$281.1M
$288.0M
Q2 24
$260.9M
$254.8M
Q1 24
$262.7M
$208.3M
Total Debt
BROS
BROS
CLOV
CLOV
Q4 25
$202.5M
Q3 25
$202.3M
Q2 25
$203.3M
Q1 25
$284.2M
Q4 24
$238.0M
Q3 24
$241.2M
Q2 24
$244.3M
Q1 24
$247.5M
Stockholders' Equity
BROS
BROS
CLOV
CLOV
Q4 25
$680.8M
$308.7M
Q3 25
$656.6M
$340.9M
Q2 25
$636.2M
$344.2M
Q1 25
$599.1M
$336.1M
Q4 24
$537.4M
$341.1M
Q3 24
$523.1M
$342.2M
Q2 24
$509.1M
$324.9M
Q1 24
$417.1M
$292.5M
Total Assets
BROS
BROS
CLOV
CLOV
Q4 25
$3.0B
$541.0M
Q3 25
$2.9B
$559.7M
Q2 25
$2.8B
$575.0M
Q1 25
$2.8B
$583.7M
Q4 24
$2.5B
$580.7M
Q3 24
$2.4B
$653.0M
Q2 24
$2.4B
$674.2M
Q1 24
$2.1B
$671.8M
Debt / Equity
BROS
BROS
CLOV
CLOV
Q4 25
0.30×
Q3 25
0.31×
Q2 25
0.32×
Q1 25
0.47×
Q4 24
0.44×
Q3 24
0.46×
Q2 24
0.48×
Q1 24
0.59×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
BROS
BROS
CLOV
CLOV
Operating Cash FlowLast quarter
$79.6M
$-66.9M
Free Cash FlowOCF − Capex
$8.5M
$-69.0M
FCF MarginFCF / Revenue
1.9%
-14.1%
Capex IntensityCapex / Revenue
16.0%
0.4%
Cash ConversionOCF / Net Profit
3.73×
TTM Free Cash FlowTrailing 4 quarters
$54.4M
$-69.2M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
BROS
BROS
CLOV
CLOV
Q4 25
$79.6M
$-66.9M
Q3 25
$89.1M
$12.1M
Q2 25
$89.9M
$5.4M
Q1 25
$36.9M
$-16.3M
Q4 24
$62.2M
$34.8M
Q3 24
$83.5M
$50.0M
Q2 24
$59.5M
$44.8M
Q1 24
$41.2M
$25.9M
Free Cash Flow
BROS
BROS
CLOV
CLOV
Q4 25
$8.5M
$-69.0M
Q3 25
$18.9M
$11.4M
Q2 25
$35.7M
$4.8M
Q1 25
$-8.7M
$-16.5M
Q4 24
$19.5M
$33.3M
Q3 24
$26.4M
$49.6M
Q2 24
$-4.9M
$44.4M
Q1 24
$-16.3M
$25.5M
FCF Margin
BROS
BROS
CLOV
CLOV
Q4 25
1.9%
-14.1%
Q3 25
4.5%
2.3%
Q2 25
8.6%
1.0%
Q1 25
-2.4%
-3.6%
Q4 24
5.7%
9.9%
Q3 24
7.8%
15.0%
Q2 24
-1.5%
12.5%
Q1 24
-5.9%
7.3%
Capex Intensity
BROS
BROS
CLOV
CLOV
Q4 25
16.0%
0.4%
Q3 25
16.6%
0.1%
Q2 25
13.0%
0.1%
Q1 25
12.8%
0.0%
Q4 24
12.5%
0.5%
Q3 24
16.9%
0.1%
Q2 24
19.8%
0.1%
Q1 24
20.9%
0.1%
Cash Conversion
BROS
BROS
CLOV
CLOV
Q4 25
3.73×
Q3 25
5.09×
Q2 25
3.51×
Q1 25
2.40×
Q4 24
17.23×
Q3 24
6.60×
Q2 24
4.99×
6.04×
Q1 24
5.83×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

BROS
BROS

Company Operated Shops$409.6M92%
Franchise Fees$32.3M7%
Other$1.8M0%

CLOV
CLOV

Segment breakdown not available.

Related Comparisons